coronavirus
cov
first
identifi
use
electron
microscopi
visual
distinct
spike
glycoprotein
project
surfac
envelop
viru
particl
quickli
recogn
cov
infect
quit
common
respons
season
local
epidem
respiratori
gastrointestin
diseas
varieti
anim
cov
name
accord
speci
isol
diseas
associ
viral
infect
avian
infecti
bronchiti
viru
ibv
infect
chicken
caus
respiratori
infect
decreas
egg
product
mortal
young
bird
bovin
coronaviru
bcov
caus
respiratori
gastrointestin
diseas
cattl
porcin
transmiss
gastroenter
viru
tgev
porcin
epidem
diarrhea
viru
pedv
caus
gastroenter
pig
cov
infect
fatal
young
anim
felin
infecti
periton
viru
fipv
canin
coronaviru
ccov
caus
sever
diseas
cat
dog
depend
strain
viru
site
infect
murin
cov
mous
hepat
viru
mhv
caus
hepat
demyelin
diseas
similar
multipl
sclerosi
cov
also
infect
human
human
coronavirus
hcov
detect
worldwid
estim
respons
common
cold
mild
gastroenter
interestingli
bcov
share
consider
sequenc
similar
indic
like
transmiss
across
speci
either
cow
human
vice
versa
adapt
viru
host
contrast
rel
mild
infect
caus
cov
respons
sever
acut
respiratori
syndrom
sarscov
caus
atyp
pneumonia
mortal
rate
two
addit
hcov
recent
identifi
use
molecular
method
associ
upper
lower
respiratori
tract
infect
children
elderli
immunosuppress
patient
cov
group
accord
sequenc
similar
cov
infect
mammal
assign
group
group
wherea
cov
infect
bird
group
date
infam
exampl
zoonot
transmiss
cov
outbreak
sar
know
outbreak
start
case
atyp
pneumonia
guangdong
provinc
southern
china
fall
infect
spread
tourist
visit
hong
kong
februari
result
dissemin
outbreak
hong
kong
vietnam
singapor
toronto
canada
attempt
treat
case
atyp
pneumonia
vietnam
acquir
infect
dr
carlo
urbani
alert
world
health
organ
diseas
unknown
origin
may
threat
public
health
rapidli
organ
intern
effort
identifi
caus
outbreak
within
month
novel
cov
isol
sar
patient
identifi
caus
agent
sequenc
analysi
reveal
viru
relat
distinct
known
cov
led
intens
search
anim
reservoir
novel
cov
initi
mask
palm
civet
raccoon
dog
implic
chain
transmiss
sinc
sarscovlik
viru
could
isol
anim
found
wild
anim
market
china
howev
sarscovlik
virus
never
detect
anim
captur
wild
indic
civet
may
serv
intermedi
host
chain
transmiss
investig
reveal
like
reservoir
sarscov
chines
horsesho
bat
rhinolophu
spp
endem
infect
viru
name
batsarscov
close
relat
sarscov
exist
anim
reservoir
present
possibl
reemerg
signific
human
pathogen
improv
understand
molecular
aspect
cov
replic
pathogenesi
may
facilit
develop
appropri
antivir
agent
vaccin
control
prevent
diseas
caus
known
potenti
emerg
cov
infect
cov
virion
figur
compos
larg
rna
genom
combin
viral
nucleocapsid
protein
n
form
helic
nucleocapsid
host
cellderiv
lipid
envelop
stud
virusspecif
protein
includ
membran
glycoprotein
envelop
e
protein
spike
glycoprotein
cov
particl
vari
somewhat
size
averag
nm
diamet
genom
rna
grna
insid
virion
rang
size
kb
differ
cov
largest
viral
rna
identifi
date
cov
grna
broadli
conserv
structur
illustr
sarscov
genom
shown
figur
cap
end
short
leader
sequenc
follow
two
long
open
read
frame
orf
encod
replicas
polyprotein
remain
part
genom
encod
viral
structur
socal
accessori
protein
structur
protein
gene
alway
found
order
semn
accessori
protein
gene
may
interspers
variou
site
structur
gene
sarscov
complex
genom
yet
identifi
eight
orf
encod
accessori
protein
express
orf
requir
viral
replic
may
play
role
pathogenesi
sar
addit
product
accessori
gene
may
incorpor
viru
particl
potenti
alter
tropism
enhanc
infect
sarscov
protein
encod
orf
shown
incorpor
viru
particl
exact
role
protein
enhanc
virul
yet
clear
featur
cov
structur
protein
shown
figur
structur
protein
schemat
diagram
predict
structur
protein
shown
left
linear
display
featur
shown
right
cov
spike
glycoprotein
essenti
attach
viru
host
cell
receptor
fusion
viru
envelop
host
cell
membran
cov
spike
glycoprotein
assembl
trimer
short
cytoplasm
tail
hydrophob
transmembran
domain
anchor
protein
membran
spike
glycoprotein
divid
region
sometim
cleav
separ
protein
cellular
proteas
matur
assembl
viru
particl
contain
receptorbind
domain
rbd
shown
provid
specif
attach
cov
particl
cellular
receptor
correspond
rbd
identifi
sever
cov
mhv
bind
murin
carcinoembryon
signal
peptid
transmembran
domain
antigenrel
cell
adhes
molecul
tgev
fipv
bind
speciesspecif
version
aminopeptidas
n
interestingli
sarscov
shown
bind
human
angiotensinconvert
enzym
express
respiratori
gastrointestin
tract
consist
viru
replic
site
portion
spike
engag
host
cell
receptor
protein
undergo
dramat
conform
chang
promot
fusion
host
cell
membran
depend
viru
strain
occur
plasma
membran
surfac
cell
acidifi
endosom
receptormedi
endocytosi
critic
element
conform
chang
heptad
repeat
fusion
peptid
f
engag
receptor
dissoci
like
trigger
rearrang
brought
togeth
form
antiparallel
sixhelix
bundl
new
conform
bring
togeth
viral
host
cell
membran
promot
fusion
lipid
bilay
introduct
nucleocapsid
cytoplasm
infect
spike
glycoprotein
also
present
surfac
infect
cell
may
depend
viru
strain
promot
fusion
neighbor
cell
syncytia
format
spike
glycoprotein
also
major
antigen
neutral
antibodi
develop
spike
protein
target
develop
therapeut
treatment
cov
infect
monoclon
antibodi
direct
spike
neutral
viru
block
bind
receptor
synthet
peptid
block
bundl
format
also
shown
block
cov
infect
membran
envelop
e
protein
essenti
effici
assembl
cov
particl
triplemembranespan
protein
abund
viral
structur
protein
cov
virion
ectodomain
gener
glycosyl
follow
three
transmembran
domain
endodomain
import
interact
nucleocapsid
protein
packag
viral
genom
e
protein
present
low
copi
number
virion
import
effici
assembl
absenc
e
protein
infecti
viru
particl
produc
exact
role
e
protein
assembl
viru
particl
still
unknown
recent
studi
suggest
e
may
act
ion
channel
nucleocapsid
protein
n
rnabind
protein
associ
cov
grna
assembl
ribonucleoprotein
complex
n
protein
phosphoryl
predominantli
serin
residu
role
phosphoryl
current
unknown
n
protein
three
conserv
domain
separ
highli
variabl
spacer
element
domain
rich
arginin
lysin
residu
typic
mani
rnabind
protein
domain
essenti
interact
protein
assembl
infecti
viru
particl
n
protein
shown
import
cofactor
cov
rna
synthesi
propos
act
rna
chaperon
promot
templat
switch
describ
replic
transcript
cov
rna
take
place
cytoplasm
infect
cell
figur
cov
virion
attach
host
cell
receptor
via
spike
glycoprotein
depend
viru
strain
spike
mediat
fusion
directli
plasma
membran
viru
undergo
receptormedi
endocytosi
spikemedi
fusion
endosom
membran
releas
viral
grna
cytoplasm
positivestrand
rna
genom
releas
act
messeng
rna
mrna
end
translat
ribosom
gener
viral
rnadepend
rna
polymeras
polyprotein
term
viral
replicas
translat
depend
ribosom
frameshift
facilit
slipperi
sequenc
rna
pseudoknot
structur
present
cov
grna
replicas
polyprotein
process
replicaseencod
proteas
papainlik
proteas
polioviru
proteas
gener
matur
replicas
product
viral
replicas
protein
sequest
host
cell
membran
gener
distinct
doublemembran
vesicl
dmv
shown
site
cov
rna
synthesi
replicas
complex
dmv
mediat
replic
positivestrand
rna
genom
gener
fulllength
subgenom
negativestrand
rna
subsequ
product
positivestrand
grna
sgmrna
sgmrna
translat
gener
viral
structur
accessori
protein
viru
particl
assembl
positivestrand
grna
endoplasm
reticulumgolgi
intermedi
compart
ergic
bud
vesicl
subsequ
releas
cell
depend
viru
strain
replic
robust
result
destruct
host
cell
lowlevel
persist
infect
maintain
cultur
cell
infect
anim
hallmark
cov
transcript
gener
nest
set
mrna
mrna
ident
leader
sequenc
approxim
nt
end
figur
leader
sequenc
encod
end
grna
subgenom
mrna
sgmrna
ident
leader
sequenc
fuse
end
bodi
sequenc
leadercontain
mrna
gener
cov
transcript
current
evid
support
model
discontinu
transcript
wherebi
replicas
complex
switch
templat
synthesi
negativestrand
rna
figur
b
key
sequenc
element
process
transcript
regulatori
sequenc
tr
tr
sequenc
approxim
nt
sarscov
found
end
leader
sequenc
intergen
region
site
open
read
frame
encod
viral
structur
accessori
protein
sitedirect
mutagenesi
delet
analysi
reveal
critic
role
tr
mediat
transcript
sgmrna
delet
intergen
tr
result
loss
product
correspond
sgmrna
addit
cov
leader
tr
intergen
tr
sequenc
must
ident
optim
product
sgmrna
threestep
work
model
templat
switch
negativestrand
rna
synthesi
propos
describ
process
gener
cov
leadercontain
sgmrna
figur
b
process
end
end
grna
form
complex
host
cell
factor
viral
replic
complex
end
posit
strand
use
templat
initi
transcript
negativestrand
rna
negativestrand
rna
synthesi
continu
point
tr
tr
viral
replicas
may
either
read
sequenc
gener
longer
templat
switch
templat
copi
leader
sequenc
templat
switch
allow
gener
leadercontain
sgmrna
model
align
leader
tr
newli
synthes
negativestrand
rna
genom
tr
critic
templat
switch
occur
disrupt
complex
loss
basepair
within
complex
result
loss
product
sgmrna
studi
cov
replic
complex
may
yield
new
insight
role
viral
helicas
endoribonucleas
gener
leadercontain
cov
rna
anoth
hallmark
cov
replic
highfrequ
rna
recombin
rna
recombin
occur
partial
synthes
viral
rna
dissoci
one
templat
hybrid
similar
sequenc
present
second
templat
viral
rna
synthesi
continu
gener
progeni
viru
sequenc
two
differ
parent
genom
rna
recombin
event
term
copychoic
recombin
copychoic
rna
recombin
demonstr
experiment
two
close
relat
cov
strain
mhvjhm
use
coinfect
cell
recombin
virus
crossov
site
throughout
genom
isol
although
sequenc
within
spike
glycoprotein
may
hot
spot
recombin
due
presenc
rna
secondari
structur
may
promot
dissoci
reassoci
rna
propos
copychoic
recombin
also
mechan
mani
cov
acquir
accessori
gene
exploit
experiment
delet
insert
specif
sequenc
cov
genom
assess
role
viru
replic
pathogenesi
sequenc
analysi
cov
isol
speci
rang
bird
human
reveal
cov
encod
core
canon
set
gene
replicas
rep
spike
envelop
e
membran
nucleocapsid
n
addit
socal
accessori
gene
tabl
canon
gene
alway
found
order
genom
repsemn
revers
genet
studi
see
shown
minim
set
gene
requir
effici
replic
assembl
infecti
cov
particl
howev
genom
cov
sequenc
date
encod
one
eight
addit
orf
code
accessori
protein
avian
ibv
name
impli
accessori
protein
requir
cov
replic
tissu
cultur
cell
line
may
play
import
role
tropism
pathogenesi
vivo
addit
gene
acquir
current
evid
indic
addit
sequenc
may
acquir
rna
recombin
event
coinfect
virus
exampl
hemagglutininesteras
glycoprotein
present
four
differ
cov
mhv
bcov
like
acquir
recombin
ancestr
cov
glycoprotein
gene
influenza
c
interestingli
express
gene
effect
replic
viru
cultur
cell
line
shown
enhanc
virul
infect
anim
cov
accessori
gene
may
acquir
recombin
host
cell
mrna
viral
mrna
specif
role
accessori
protein
cov
replic
pathogenesi
investig
sarscov
accessori
protein
implic
import
factor
viral
pathogenesi
research
shown
mice
infect
murin
covexpress
sarscov
protein
rapidli
succumb
infect
indic
protein
enhanc
virul
addit
recent
studi
suggest
sarscov
accessori
protein
may
play
role
block
host
cell
innat
immun
respons
may
enhanc
viral
replic
virul
accessori
protein
sarscov
shown
packag
viru
particl
may
enhanc
infect
alter
cell
tropism
futur
studi
aim
elucid
cov
accessori
protein
may
modul
virul
cov
infect
genet
manipul
cov
sequenc
challeng
larg
size
kbp
rna
genom
howev
two
approach
develop
allow
research
introduc
mutat
delet
report
gene
cov
genom
approach
target
rna
recombin
revers
genet
use
infecti
cdna
construct
cov
first
approach
exploit
highfrequ
copychoic
recombin
introduc
mutat
interest
end
cov
grna
first
step
target
rna
recombin
cdna
clone
encod
region
spike
glycoprotein
end
rna
gener
sequenc
easili
manipul
laboratori
introduc
mutat
delet
insert
report
accessori
gene
plasmid
dna
next
rna
transcrib
plasmid
dna
rna
transfect
cell
coinfect
cov
interest
rna
recombin
occur
replic
cov
transfect
substrat
rna
virus
end
sequenc
deriv
transfect
substrat
rna
gener
recombin
virus
gener
highfrequ
copychoic
recombin
challeng
sort
select
recombin
viru
interest
background
wildtyp
viru
facilit
select
recombin
virus
master
rottier
introduc
idea
host
rangebas
select
devis
clever
plan
use
mous
hepat
viru
mhv
encod
spike
glycoprotein
felin
cov
target
recombin
experi
felinemhv
term
fmhv
infect
felin
cell
line
substrat
rna
encod
mhv
spike
mutat
interest
region
genom
transfect
felin
cell
infect
fmhv
progeni
viru
collect
supernat
subsequ
select
abil
infect
murin
cell
line
recombin
cov
incorpor
mhv
spike
gene
sequenc
downstream
substrat
rna
mutat
interest
select
growth
murin
cell
thu
allow
rapid
isol
recombin
viru
interest
host
rangebas
select
step
wide
use
virologist
gener
recombin
virus
specif
alter
end
cov
genom
second
approach
manipul
cov
sequenc
gener
infecti
cdna
construct
cov
develop
sever
laboratori
fulllength
cov
sequenc
clone
express
use
bacteri
artifici
chromosom
bac
vaccinia
viru
vector
assembl
set
cdna
clone
repres
entir
cov
genom
gener
fulllength
cdna
subsequ
gener
fulllength
cov
grna
allow
revers
genet
analysi
cov
sequenc
success
revers
genet
system
place
studi
replic
pathogenesi
sarscov
mhv
ibv
revers
genet
system
allow
research
introduc
mutat
replicas
gene
identifi
site
critic
enzymat
activ
mani
replicas
product
helicas
endoribonucleas
papainlik
proteas
revers
genet
approach
also
use
investig
role
trss
control
synthesi
cov
mrna
interestingli
sarscov
genom
rewir
use
novel
nonanon
tr
sequenc
must
present
end
leader
sequenc
intergen
junction
rewir
sarscov
may
use
gener
liveattenu
sarscov
vaccin
import
featur
rewir
viru
would
nonviabl
recombin
wildtyp
viru
sinc
leader
tr
downstream
tr
would
longer
match
recombin
viru
develop
revers
genet
system
cov
open
door
investig
replicas
gene
product
function
complex
mechan
cov
discontinu
transcript
provid
new
opportun
gener
novel
cov
potenti
liveattenu
kill
viru
vaccin
reduc
prevent
cov
infect
human
anim
econom
import
cov
infect
livestock
domest
anim
varieti
liveattenu
kill
cov
vaccin
test
anim
vaccin
develop
ibv
tgev
ccov
fipv
howev
vaccin
seem
provid
complet
protect
wildtyp
viru
infect
case
wildtyp
cov
rapidli
evolv
escap
neutral
vaccineinduc
antibodi
studi
vaccin
chicken
liveattenu
ibv
vaccin
shown
undergo
rna
recombin
wildtyp
viru
gener
vaccin
escap
mutant
kill
viru
vaccin
may
also
problemat
cov
infect
vaccin
cat
kill
fipv
vaccin
shown
exacerb
diseas
cat
challeng
wildtyp
viru
therefor
extens
studi
requir
care
evalu
candid
vaccin
sarscov
varieti
approach
current
investig
develop
sarscov
vaccin
includ
analysi
kill
viru
vaccin
liveattenu
viru
vaccin
dna
immun
viral
vector
vaccin
modifi
vaccin
viru
ankara
canarypox
alphaviru
adenoviru
vector
develop
improv
anim
model
sar
essenti
evalu
sarscov
candid
vaccin
transgen
mice
express
human
may
appropri
small
anim
model
initi
studi
suggest
syrian
hamster
ferret
develop
pneumonia
lung
patholog
similar
seen
human
infect
sarscov
therefor
may
appropri
anim
model
viral
pathogenesi
cov
vaccin
studi
benefit
improv
understand
conserv
viral
epitop
target
vaccin
develop
use
neutral
monoclon
antibodi
direct
sarscov
spike
glycoprotein
anoth
approach
may
provid
protect
sever
diseas
success
develop
use
human
monoclon
antibodi
respiratori
syncyti
viru
famili
paramyxovirida
protect
infant
sever
diseas
indic
approach
certainli
worth
investig
preliminari
studi
indic
patient
convalesc
serum
monoclon
antibodi
direct
sarscov
spike
glycoprotein
effici
neutral
infecti
viru
studi
essenti
evalu
concern
potenti
antibodymedi
enhanc
diseas
determin
neutral
escap
mutant
aris
rapidli
challeng
infecti
viru
studi
evalu
monoclon
antibodi
direct
varieti
structur
protein
monoclon
antibodi
direct
conserv
site
spike
glycoprotein
provid
import
inform
efficaci
passiv
immun
protect
sar
current
antivir
drug
approv
use
human
cov
infect
potenti
emerg
reemerg
pathogen
cov
anim
reservoir
consider
interest
identifi
potenti
therapeut
target
develop
antivir
drug
block
viral
replic
reduc
sever
cov
infect
human
two
promis
target
antivir
drug
develop
sarscov
proteas
domain
papainlik
proteas
pl
pro
proteas
pro
also
term
main
proteas
pro
figur
two
proteas
domain
encod
within
replicas
polyprotein
gene
proteas
activ
requir
gener
replicas
nonstructur
protein
assembl
gener
viral
replic
complex
crystal
structur
pro
determin
first
tgev
sarscov
ration
drug
design
much
base
knowledg
inhibitor
direct
rhinoviru
proteas
provid
promis
lead
compound
pro
antivir
drug
develop
interestingli
candid
antivir
shown
inhibit
replic
sarscov
group
cov
mhv
less
relat
group
cov
indic
activ
site
pro
highli
conserv
among
cov
antivir
drug
develop
sarscov
pro
may
also
use
inhibit
replic
common
human
cov
studi
need
determin
inhibitor
develop
clinic
use
antivir
agent
analysi
sarscov
papainlik
proteas
led
surpris
discoveri
proteas
also
viral
deubiquitin
dub
enzym
sarscov
pl
pro
shown
requir
process
aminotermin
end
replicas
polyprotein
recogn
conserv
cleavag
site
lxgg
lxgg
cleavag
site
also
site
recogn
cellular
dub
remov
polyubiquitin
chain
protein
target
degrad
proteasom
analysi
xray
structur
sarscov
pl
pro
reveal
structur
similar
known
cellular
dub
studi
suggest
cov
papainlik
proteas
evolv
proteolyt
process
dub
activ
dub
activ
may
import
prevent
ubiquitinmedi
degrad
viral
protein
dub
activ
may
import
subvert
host
cell
pathway
enhanc
viral
replic
pl
pro
inhibitor
develop
use
structur
inform
perform
highthroughput
screen
small
molecul
librari
identifi
lead
compound
addit
cov
replicas
protein
particularli
rnadepend
rna
polymeras
helicas
endoribonucleas
also
target
antivir
drug
develop
develop
target
rna
recombin
revers
genet
system
cov
provid
new
opportun
address
import
question
concern
mechan
cov
replic
virul
design
novel
cov
vaccin
futur
improv
small
anim
model
test
vaccin
antivir
avail
addit
xray
crystallograph
structur
inform
ration
drug
design
critic
progress
toward
develop
effect
vaccin
antivir
drug
prevent
reduc
diseas
caus
cov
